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A B S T R A C T
Anemia is a prevalent finding in patients with type 1 diabetes, particularly in those with albuminuria or reduced re-
nal function. We investigated the relationship between red blood cell count (RBC) and renal function in type 1 diabetic
patients with normal or mildly impaired renal function and urinary albumin excretion rate (UAE) <30 mg/24 h. Study
included 313 type 1 diabetic patients with estimated glomerular filtration rate (eGFR) > 60 mL min–11.73 m–2, and be-
fore any interventions with statins, ACE inhibitors or angiotensin II receptor blockers. UAE was measured from at least
two 24-h urine samples. Hemoglobin (Hb), hematocrit (Hct), erythrocytes (E), serum iron and ferritin levels were signifi-
cantly lower in subjects in the highest quartile of serum creatinine compared to those in lowest quartile (132 vs 148 g/L,
0.39 vs 0.42 L/L, 4.5 vs 4.8x1012/L, 13 vs 18 µmol/L, and 25 vs 103 µg/L, respectively, for all p<0.001). Hb and Hct levels
were significantly lower in subjects in the highest quartile of UAE compared to those in lowest quartile (135 vs 140 g/L,
and 0.40 vs 0.41 L/L, respectively, for all p=0.03). Finally, those with mildly impaired eGFR had significantly lower lev-
els of Hb, Hct and E compared to those with normal eGFR or hyperfiltrating subjects (133 vs 140 g/L, 0.38 vs 0.41 L/L,
and 4.4 vs 4.7x1012/L, respectively, for all p=0.01). We have detected that interplay between RBC and renal function pa-
rameters occurs even in type 1 diabetic patients with normal or mildly impaired renal function.
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Introduction
Anemia is a common feature in diabetic patients with
chronic kidney disease (CKD) and patients with type 1
diabetes have a 20–50% probability of developing end-
-stage renal disease1. Diabetes itself has been proposed to
affect the hematologic system in several ways and nearly
a quarter of all diabetic patients have anemia2,3. Anemia
in diabetic patients develops earlier than in subjects with
renal disease from other causes3–5. However, it has been
demonstrated that anaemia may occur in diabetic pa-
tients already in state with mildly to moderate renal
insufficiency4,6. Declining hemoglobin levels in early kid-
ney disease are more common among those with higher
levels of albuminuria3,7. Anemia is also more common in
patients with impaired kidney function, even in state of
normal to mildly increased urinary albumin excretion
rate (UAE)3. In addition, those with reduced hemoglobin
have higher risk of progressive renal disease and have a
more rapid decline in glomerular filtration rate (GFR)8.
Moreover, recent study demonstrated that anemia is a
prevalent finding in patients with type 1 diabetes and
represents a significant unrecognized burden9. In addi-
tion, reduced hemoglobin levels, even within the normal
range, identify diabetic patients with an increased risk of
cardiovascular morbidity and mortality10,11. Treating
anemia in early renal disease may slow the rate of decline
of renal function12.
Identification of the determinants of the onset of
early diabetic nephropathy is essential for reducing the
morbidity and mortality associated with diabetes. Al-
though previous studies demonstrated that anemia is as-
sociated with reduced GFR and increased albuminuria in
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patients with established renal disease, little is known
about the relationship between red blood cell count
(RBC) and change in renal function among individuals
with normal or mildly impaired renal function. The ob-
jective of this study was to investigate relationship be-
tween RBC and renal function parameters in type 1 dia-
betic patients with normal or mildly impaired renal
function (eGFR > 60 mL/min/1.73 m2, and UAE<30
mg/24 h).
Subjects, Materials and Methods
This study included 313 patients with diabetes melli-
tus type 1. Type 1 diabetes was defined as an onset of dia-
betes before the age of 35 years, positive autoantibodies
and permanent insulin treatment initiated within 1 year
of diagnosis. The study included patients with following
characteristics: age of 18–65 years, minimum duration of
type 1 diabetes for 1 year, no medical history of liver, re-
nal and cardiovascular diseases, absence of any systemic
disease, and absence of any infections in the previous
month. Patients were excluded from the study if they
took any of the following: lipid-lowering therapy, anti-
hypertensive therapy including ACE inhibitor or angio-
tensin II receptor blockers, and medications that might
affect glucose metabolism such as glucocorticoids. Acute
and chronic inflammation was excluded on the basis of
medical history, physical examination, and routine labo-
ratory tests, including measurement of temperature and
urinalysis.
All subjects were studied in the morning after an
overnight fast. Basic anthropometric measurements
were performed on all study subjects. Blood pressure was
measured twice in the sitting position with a mercury
sphygmomanometer after a resting period of 10 minutes
and expressed in mmHg. UAE was measured from at
least two 24-h urine samples and determined as the
mean of 24-h urine collections. Patients performed col-
lections on two consecutive days to minimize variability.
Normal to mildly increased UAE was defined as a UAE
<30 mg/24 h. Those with moderate increased UAE (³30
<300 mg/24 h) and those with severely increased UAE
(³300 mg/24 h) were excluded from the study. Serum
creatinine was measured in fasting blood sample. Crea-
tinine measurements were made on Olympus AU600, by
the spectrophotometric Jaffé method. Data on serum
creatinine levels, age, sex and race were used to calculate
the estimated glomerular filtration rate (eGFR) using
the Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) formula, which has been shown to be accu-
rate in determining renal function in diabetic patients
with normal renal function13,14. Those with CKD, defined
as the presence of impaired eGFR (less than 60 mL min–1
1.73 m–2), were excluded from the study.
Fasting venous blood samples were collected in the
morning between 08:00 and 09:30 hours after an over-
night fast for the determination of HbA1c, total, LDL,
HDL cholesterol, triglycerides, ferritin, iron, hemoglobin
(Hb) and erythrocytes (E). Urinary albumin and HbA1c
was measured spectrophotometrically by turbidimetric
immuno-inhibition (Olympus AU600, Beckman-Coulter,
USA). Cholesterol and triglycerides in serum were mea-
sured by an enzymatic colorimetric method. Complete
blood count was determined on an automatic blood coun-
ter (Advia 120, Siemens Diagnostic Solutions, USA).
The study protocol complies with the Declaration of
Helsinki as well as with local institutional guidelines,
and was approved by the local ethics committees.
Data are expressed as means ±SD for normally dis-
tributed values, as median with range for non-normally
distributed values, and percentage. Pearson’s correlation
coefficients were used to calculate correlations between
normally distributed values and Spearman’s rank corre-
lation coefficients were used for non-normally distrib-
uted values. To investigate the relation between RBC
and renal function parameters data were also stratified
in quartiles of UAE and serum creatinine according to
percentiles. Parameters were also stratified in different
groups of eGFR according to stages of renal function,
namely in those with mildly impaired renal function
(eGFR ³ 60<90 mL/min/1.73 m2), with normal renal
function (eGFR ³ 90<125 mL/min/1.73 m2), and hyper-
filtrating subjects (eGFR ³ 125 mL/min/1.73 m2). Krus-
kal-Wallis test was used for calculating the significance of
the trend for each variable among the different groups.
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TABLE 1
CLINICAL AND METABOLIC CHARACTERISTICS
OF ALL PATIENTS
Variable Value
Age (years) 34 (18–65)
Duration of diabetes (years) 12 (1–42)
Body mass index (kg/m2) 24 (15–37)
Waist to hip ratio 0.81±0.07
Hemoglobin A1c (%) 7.43±1.63
Systolic blood pressure (mmHg) 120 (79–180)
Diastolic blood pressure (mmHg) 80 (50–100)
LDL cholesterol (mmol/L) 2.8±0.7
HDL cholesterol (mmol/L) 1.7±0.4
Triglycerides (mmol/L) 0.91 (0.3–4.1)
Serum creatinine (µmol/L) 71±14
eGFR (mL min–1 1.73 m–2) 106±16
Urinary albumin excretion (mg/24 h) 11.0 (1.7–29.8)
Erythrocytes (x1012/L) 4.66±0.4
Haemoglobin (g/L) 139±16
MCV (fL) 88 (57–124)
Hematocrit (L/L) 0.41±0.04
Ferritin (µg/L) 55 (5–697)
Serum iron (µmol/L) 16 (2–62)
UIBC (µmol/L) 36.3±11.1
TIBC (µmol/L) 53.7±8.0
eGFR – estimated glomerular filtration rate,
MCV – mean corpuscular volume
Level of statistical significance was chosen to be a=0.05.
Statistical analysis was performed by statistical package
STATA/IC ver.11.1.
Results
The characteristics of the study subjects are listed in
Table 1. Mean/median values of BMI, waist to hip ratio
(WHR), HDL cholesterol, triglycerides, E, Hb, serum
iron, ferritin, serum creatinine, UAE, eGFR as well as
blood pressure were within the normal range for patients
with diabetes, with slightly elevated HbA1c and LDL
cholesterol levels. Association between RBC and parame-
ters of renal function are presented in Table 2. Serum
creatinine was significantly associated with Hb, hema-
tocrit (Hct), E, serum iron and ferritin, with Hb showing
the strongest correlation (r= –0.42, p<0.001). eGFR was
significantly associated with Hb, Hct and E, with Hct
showing the strongest correlation (r=0.18, p=0.001).
However, UAE did not significantly correlated with RBC.
In addition, RBC and renal parameters significantly cor-
related with various metabolic variables, mainly with pa-
rameters included in diagnosis of metabolic syndrome
(BMI, WHR, HbA1c, HDL cholesterol, triglycerides and
blood pressure). The mentioned correlations were most
significant for WHR and HDL cholesterol.
Relationship between RBC among those in the 2nd, 3rd
and 4th quartiles of serum creatinine compared to those
in quartile 1 are presented in table 3. Stratifying RBC for
the degree of serum creatinine, trends across quartiles of
serum creatinine for Hb, Hct, E, serum iron and ferritin
were statistically significant (all p<0.001). Subjects in
the 4th quartile of serum creatinine had significantly
lower Hb, Hct, E, serum iron and ferritin levels com-
pared to subjects in 1st, 2nd, and 3rd quartiles. We also ex-
plore relationship between RBC among those in the 2nd,
3rd and 4th quartiles of UAE compared to those in quar-
tile 1 (<6.8 mg/24 h). Stratifying RBC for degree of UAE,
trends across quartiles was statistically significant only
for Hb and Hct (p=0.03) (Table 4).
Relationship between RBC among subjects with nor-
mal, mildly decreased renal function or with renal hyper-
filtration is displayed in Table 5. Stratifying RBCmarkers
for the degree of eGFR, trends across different groups for
Hb, Hct and E were statistically significant (all p=0.01).
Subjects with eGFR ³ 125 mL min–1 1.73 m–2 had signifi-
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TABLE 2
SPEARMAN CORRELATION ANALYSIS OF ASSOCIATIONS OF RED BLOOD CELL COUNT WITH RENAL FUNCTION PARAMETERS
AND METABOLIC PARAMETERS
Variable Hb Hct E iron ferritin creatinine UAE eGFR
Duration of diab. –0.15* –0.15* –0.15* –0.00 –0.13* 0.00 0.14* –0.29*
BMI 0.16* 0.18* 0.22* 0.09 0.09 0.15* –0.02 –0.10
WHR 0.52* 0.51* 0.41* 0.24* 0.56* 0.39* 0.01 –0.02
HBA1c 0.00 0.03 –0.04 0.13* 0.07 –0.14* 0.07 0.15*
LDL cholesterol 0.06 0.11* 0.08 0.00 0.07 0.08 0.03 –0.18*
HDL cholesterol –0.33* –0.33* –0.32* –0.11* –0.23* –0.19* –0.13* –0.17*
Triglycerides 0.12* 0.14* 0.09 –0.01 0.24* 0.07 0.11* 0.06
Systolic BP 0.18* 0.22* 0.15* 0.15* 0.13* 0.11* 0.09 –0.08
Diastolic BP 0.17* 0.19* 0.16* 0.07 0.19* 0.08 0.23* –0.01
Serum creatinine –0.42* –0.33* –0.32* –0.23* –0.39*
eGFR 0.11* 0.18* 0.17* –0.04 0.11
UAE –0.03 –0.05 –0.06 0.06 –0.03
BMI – body mass index, WHR – waist to hip ratio, HbA1c – hemoglobin A1c, eGFR – estimated glomerular filtration rate, UAE – uri-
nary albumin excretion rate, Hb – hemoglobin, Hct –hematocrit, E – erythrocytes, *P<0.05
TABLE 3
QUARTILES OF SERUM CREATININE
1st quartile 2nd quartile 3rd quartile 4th quartile P
(<63 µmol/L) (³63<71) (³71<80) (³80 µmol/L) for trend
Hemoglobin (g/L) 148±12 142±17 137±17 132±11 <0.001
Hematocrit (L/L) 0.42±0.03 0.41±0.04 0.40±0.05 0.39±0.03 <0.001
E (x1012/L) 4.8±0.6 4.7±0.5 4.5±0.4 4.5±0.3 <0.001
Iron (µmol/L) 18 (8–41) 18 (3–46) 16 (2–63) 13 (2–46) <0.001
Ferritin (µg/L) 103 (8–231) 80 (8–316) 52 (5–697) 25 (8–231) <0.001
E – Erythrocytes
cantly higher levels of Hb, Hct and E than subjects with
an eGFR below 125 mL min–1 1.73 m–2.
Discussion
Previous studies documented that anemia is a preva-
lent finding in patients with type 1 diabetes, especially in
those with albuminuria and reduced kidney function,
and may contribute to development of CKD in diabetic
subjects1,3–7. Moreover, anemia is associated with risk of
other microvascular complications in diabetes including
retinopathy and neuropathy as well as with impaired
cognitive functions, increased rates of hospitalization
and premature mortality9,15,16. On the other hand, the
presence and severity of CKD predicts all-cause mortal-
ity in type 1 diabetes, and only patients with eGFR >60
mL/min and UAE<30mg/24 h have no increased risk17,18.
In the present study we found significant associations
between RBC and renal function parameters in type 1 di-
abetic patients with normal or mildly decreased renal
function and UAE <30 mg/24 h. Furthermore, we dem-
onstrated that concentrations of E, Hb, Hct, serum iron
and ferritin worsened in parallel with increased in quar-
tiles of serum creatinine and Hb and Hct with increased
in quartiles of UAE. In addition, concentrations of E, Hb
and Hct were lower in subjects with mildly impaired re-
nal function compared those with normal eGFR or hype-
rfiltrating subjects. Although previous studies found that
significant correlation between RBC and GFR occurs in
patients with eGFR < 60 mL/min, we demonstrated sig-
nificant associations in subjects with normal renal func-
tion6. In addition, therapy with ACE-inhibitors may cau-
se a small decrease of RBC, but none of our studied pa-
tients were treated with ACE inhibitors or angiotensin II
receptor blockers19.
Risk of anemia in diabetes is approximately two to
three times that of general population, independently of
level of GFR3. In type 1 diabetic patients anemia associa-
ted with nephropathy is consequence of Epo deficiency
and it may be present already in state of normal serum
creatinine levels4. In type 2 diabetic patients without
nephropathy and with UAE < 30 mg/24 h normal increa-
se in Epo production in response to lowering levels of Hb
was demonstrated, but without expected reticulocyte
response20. Microvascular damage and autonomic neuro-
pathy, conditions closely associated with type 1 diabetes,
may play role in interstitial fibrosis and consequence im-
paired function of Epo-producing fibroblasts leading to
anemia21,22. In addition, reduced sympathetic stimula-
tion of erythropoietin production occurs in diabetic auto-
nomic neuropathy23. Severity of this tubulointerstitial
injury correlates better with UAE than with GFR24.
Moreover, declining Hb levels in diabetic patients with
early kidney disease are more common among those with
higher levels of albuminuria7. In this study we also found
that Hb and Hct levels were significantly lower in sub-
jects with higher levels of albuminuria.
Although ferritin levels are not an accurate reflection
of iron indices in diabetes, levels of ferritin and serum
iron worsened in parallel with increasing in serum crea-
tinine in our subjects. Patients with CKD have both ab-
solute and relative iron deficiency25,26. Absolute iron defi-
ciency is usually evidenced by a serum ferritin level <100
µg/L, which have majority of our patients. Moreover, only
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TABLE 4
QUARTILES OF URINARY ALBUMIN EXCRETION RATE
1st quartile 2nd quartile 3rd quartile 4th quartile P
(<6.8 mg/24 h) (³6.8<11.0) (³11.0<16.7) (³16.7 mg/24 h) for trend
Hemoglobin (g/L) 140±14 139±16 143±15 135±17 0.03
Hematocrit (L/L) 0.41±0.04 0.40±0.04 0.42±0.04 0.40±0.04 0.03
E (x1012/L) 4.7±0.4 4.6±0.5 4.7±0.4 4.6±0.4 0.07
Iron (µmol/L) 15 (3–46) 17 (3–40) 17 (2–62) 16 (2–46) 0.2
Ferritin (µg/L) 60 (5–335) 52 (8–460) 76 (5–697) 40 (7–374) 0.3
E – Erythrocytes
TABLE 5
LEVELS OF RED BLOOD CELL COUNT DEPENDING ON LEVEL OF ESTIMATED GLOMERULAR FILTRATION RATE
Variable eGFR³60<90 eGFR³90<125 eGFR³125 P
mL min–1 1.73 m–2 mL min–1 1.73 m–2 mL min–1 1.73 m–2
Hemoglobin (g/L) 133±20 141±14 140±13 0.01
Hematocrit (L/L) 0.38±0.05 0.41±0.04 0.41±0.03 0.001
Erythrocytes (x1012/L) 4.4±0.5 4.7±0.4 4.7±0.3 0.003
Fe (µmol/L) 15 (2–29) 17 (2–62) 14 (3–46) 0.1
Ferritin (µg/L) 33 (7–413) 66 (5–697) 54 (13–194) 0.07
eGFR – estimated glomerular filtration rate
those in the lowest quartile of serum creatinine (indicat-
ing highest GFR) have serum ferritin level > 100 µg/L.
In addition, it has been demonstrated that elevated iron
indices are more common in patients with type 1 diabe-
tes, especially in those with poor glycemia and hyperfil-
tration, which is not confirmed in this study27,28. How-
ever, our patients with hyperfiltration have higher E, Hb
and Hct levels. Hyperfiltration has been suggested as a
risk factor for the development of albuminuria and pro-
gressive nephropathy29. However, recent prospective stu-
dy including large cohort of type 1 diabetic patients with
UAE <30 mg/24 h found that the distribution of esti-
mated GFR in adults type 1 diabetic patients was not sig-
nificantly different from general population and that
type 1 diabetic patients with a higher eGFR were no
more likely to develop moderate increased UAE30.
The present study has a number of potential limita-
tions. First, our study was cross-sectional, which limited
our ability to infer a causal relationship between RBC
markers and risk for the progression of renal disease in
type 1 diabetes. Second, we used estimated GFR rather
than more precise measures of kidney function. Third,
we did not use sophisticated measures of hematinic para-
meteters such as erythropoietin. Fourth, our analyses
were based on measurement of UAE, serum creatinine
and eGFR on two consecutive days that may not reflect
the relation over time. Fifth, we have not excluded auto-
immune gastritis in our patients which may be associa-
ted with lower RBC.
In conclusion, anemia is a common finding in type 1
diabetic patients associated with cardiovascular risk and
progression of renal disease. Significant associations bet-
ween RBC and renal function parameters even in type 1
diabetic patients with eGFR >60 mL/min and UAE <30
mg/24 h suggest that the interplay between RBC and re-
nal function exist in the absence of nephropathy. Since
progression to chronic renal disease, as a main predictor
of all-cause mortality in type 1 diabetes, is likely to occur
in majority of diabetic patients, there is a need to further
explore the role of risk factors such as anemia.
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POVEZANOST IZME\U CRVENE KRVNE SLIKE I BUBRE@NE FUNKCIJE JE PRISUTNA
U BOLESNIKA SA [E]ERNOM BOLE[]U TIPA 1 BEZ NEFROPATIJE
S A @ E T A K
Anemija je ~esta u bolesnika sa tipom 1 {e}erne bolesti, a posebno u onih s albuminurijom ili sni`enom bubre`nom
funkcijom. Istra`ivali smo povezanost crvene krvne slike i bubre`ne funkcije u bolesnika s tipom 1 {e}erne bolesti s
normalnom ili blago sni`enom bubre`nom funkcijom i razinom albumina u urinu (AU) <30 mg/24 h. Istra`ivanje je
obuhvatilo 313 bolesnika sa tipom 1 {e}erne bolesti s urednom ili blago sni`enom glomerularnom filtracijom (GF >60
mL/min/1,73 m2), s AU <30 mg/24 h i bez terapije statinima, ACE-inhibitorima ili blokatorima angiotenzinskih recep-
tora. Razina hemoglobina (Hb), hematokrita (Hct), eritrocita (E), serumskog `eljeza i feritina je bila zna~ajno ni`a u
bolesnika u najvi{oj kvartili serumskog kreatinina u odnosu na one u najni`oj kvartili (132 vs 148 g/L, 0.39 vs 0,42 L/L,
4,5 vs 4,8x1012/L, 13 vs 18 µmol/L, i 25 vs 103 µg/L, p<0,001). Razina Hb i Hct je bila zna~ajno ni`a u bolesnika u
najvi{oj kvartili AU u odnosu na one u najni`oj kvartili (135 vs 140 g/L, i 0,40 vs 0,41 L/L, p=0,03). Bolesnici s blago
sni`enom GF su imali zna~ajno ni`u razinu Hb, Hct i E u odnosu na one s urednom GF ili hiperfiltracijom (133 vs 140
g/L, 0,38 vs 0,41 L/L, i 4.4 vs 4,7x1012/L, p=0,01). Rezultati istra`ivanja ukazuju da povezanost crvene krvne slike i
bubre`ne funkcije postoji ve} u bolesnika s tipom 1 {e}erne bolesti s normalnom ili blago sni`enom bubre`nom funk-
cijom te AU <30 m/24 h.
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